Cancer Liver Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Liver Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Liver Cancer Projects
--Bristol-Myers Squibb Company
--Abbott Laboratories
--Dainippon Sumitomo Pharma Co., Ltd.
--Celgene Corporation
--Genta Incorporated
--Genentech Inc
--MediGene AG
--Genzyme Corporation
--MolMed S.p.A.
--MGI Pharma, Inc.
--Pfizer Inc
--Otsuka Pharmaceutical Co., Ltd.
--Pharmexa A/S
--PharmaMar
--SciClone Pharmaceuticals Inc
--Roche Holdings Ltd
--Topotarget A/S
--Sigma-Tau S.p.A.
--WILEX AG
--TTY BioPharm

--Top Companies in early stage Liver Cancer Projects
--ARIUS Research Inc
--Ambryx Biotechnology Inc.
--BioCancell Therapeutics, Inc.
--AUSTRIANOVA Biotechnology GmbH
--Daewoong Pharmaceutical Co. Ltd.
--Can-Fite BioPharma, Ltd.
--Geron Corporation
--ERYtech Pharma
--Kowa Company, Ltd.
--Immunomedics Inc
--Panacea Pharmaceuticals, Inc.
--LifeTec Group Limited
--Reata Pharmaceuticals, Inc.
--Protiva Biotherapeutics Inc
--Sunway Biotech Co.Ltd.
--Silence Therapeutics plc
--erly SR Pharma plc)
--Vaxart, Inc.
--Taiho Pharmaceutical Co., Ltd.
--Yissum Research Development Company
--ViRexx Medical Corp

Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View